3-(Bromomethyl)-2-fluoropyridine

Catalog No.: 
ACYZRE712
CAS No.: 
30412-42-1
Molecular Formula: 
C6H5BrFN
Molecular Weight: 
190.01
3-(Bromomethyl)-2-fluoropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg90%$139.00InquiryInquiry
250mg90%$254.00In stockInquiry
1g90%$996.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Bromomethyl)-2-fluoropyridine
IUPAC Name3-(bromomethyl)-2-fluoropyridine
MDL No.MFCD11847263
Molecular FormulaC6H5BrFN
Molecular Weight190.01
SMILESFC1=NC=CC=C1CBr
InChI KeyQTOXWFSZUMGWKX-UHFFFAOYSA-N
Synonym3-(bromomethyl)-2-fluoropyridine;Pyridine, 3-(bromomethyl)-2-fluoro-;2-Fluoro-bromomethylpyridine
CAS No.30412-42-1

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACYZRE712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVKAL593 route compound structure diagram
    ACVKAL593131747-55-2In Stock
  2. Then
  3. ACYZRE712 route product structure diagram
    ACYZRE71230412-42-1In Stock
Inquiry

2. ACYZRE712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVKAL593 route compound structure diagram
    ACVKAL593131747-55-2In Stock
  4. Then
  5. ACYZRE712 route product structure diagram
    ACYZRE71230412-42-1In Stock
Inquiry

3. ACYZRE712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACVKAL593 route compound structure diagram
    ACVKAL593131747-55-2In Stock
  6. Then
  7. ACYZRE712 route product structure diagram
    ACYZRE71230412-42-1In Stock
Inquiry

Comments (0)